Nephros, Inc.

NasdaqCM:NEPH Stock Report

Market Cap: US$60.4m

Nephros Future Growth

Future criteria checks 0/6

Nephros's earnings are forecast to decline at 55.3% per annum while its annual revenue is expected to grow at 8.8% per year. EPS is expected to decline by 56.9% per annum.

Key information

-55.3%

Earnings growth rate

-56.89%

EPS growth rate

Machinery earnings growth15.6%
Revenue growth rate8.8%
Future return on equityn/a
Analyst coverage

Low

Last updated12 Aug 2025

Recent future growth updates

Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

May 13
Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

Recent updates

Why Investors Shouldn't Be Surprised By Nephros, Inc.'s (NASDAQ:NEPH) 27% Share Price Surge

Oct 01
Why Investors Shouldn't Be Surprised By Nephros, Inc.'s (NASDAQ:NEPH) 27% Share Price Surge

At US$4.26, Is Nephros, Inc. (NASDAQ:NEPH) Worth Looking At Closely?

Sep 13
At US$4.26, Is Nephros, Inc. (NASDAQ:NEPH) Worth Looking At Closely?

It's Down 26% But Nephros, Inc. (NASDAQ:NEPH) Could Be Riskier Than It Looks

Aug 07
It's Down 26% But Nephros, Inc. (NASDAQ:NEPH) Could Be Riskier Than It Looks

Nephros, Inc.'s (NASDAQ:NEPH) 79% Jump Shows Its Popularity With Investors

Jun 16
Nephros, Inc.'s (NASDAQ:NEPH) 79% Jump Shows Its Popularity With Investors

Should You Think About Buying Nephros, Inc. (NASDAQ:NEPH) Now?

May 14
Should You Think About Buying Nephros, Inc. (NASDAQ:NEPH) Now?

Investors Still Aren't Entirely Convinced By Nephros, Inc.'s (NASDAQ:NEPH) Revenues Despite 32% Price Jump

Apr 18
Investors Still Aren't Entirely Convinced By Nephros, Inc.'s (NASDAQ:NEPH) Revenues Despite 32% Price Jump

It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)

Oct 03
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)

We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn

Jul 14
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn

Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

May 13
Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates

After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar

Dec 18
After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar

At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Dec 14
At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?

Nephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operation

Sep 28

US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results

Aug 13
US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results

Earnings and Revenue Growth Forecasts

NasdaqCM:NEPH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026191N/AN/A1
12/31/2025170N/AN/A2
6/30/202517122N/A
3/31/202516101N/A
12/31/2024140-10N/A
9/30/202414-1-2-2N/A
6/30/202414-1-1-1N/A
3/31/202414-100N/A
12/31/202314-211N/A
9/30/202314-211N/A
6/30/202312-300N/A
3/31/202312-3-1-1N/A
12/31/202210-5-3-3N/A
9/30/202210-5-4-3N/A
6/30/202210-4-4-4N/A
3/31/202210-4-3-3N/A
12/31/202110-3-2-1N/A
9/30/202110-3-3-3N/A
6/30/20219-4-4-4N/A
3/31/20219-4-5-5N/A
12/31/20209-5-7-7N/A
9/30/20209-4-5-5N/A
6/30/202010-4-4-4N/A
3/31/202011-3-3-3N/A
12/31/201910-3-2-2N/A
9/30/20199-4-3-3N/A
6/30/20197-4-4-4N/A
3/31/20196-3N/A-4N/A
12/31/20186-3N/A-4N/A
9/30/20185-1N/A-1N/A
6/30/20185-1N/A-1N/A
3/31/20184-2N/A0N/A
12/31/20174-1N/A0N/A
9/30/20173-3N/A-2N/A
6/30/20173-3N/A-2N/A
3/31/20172-3N/A-2N/A
12/31/20162-3N/A-2N/A
9/30/20162-3N/A-3N/A
6/30/20162-3N/A-3N/A
3/31/20162-4N/A-3N/A
12/31/20152-3N/A-4N/A
9/30/20152-3N/A-3N/A
6/30/201520N/A-3N/A
3/31/20152-4N/A-3N/A
12/31/20142-7N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NEPH's earnings are forecast to decline over the next 3 years (-55.3% per year).

Earnings vs Market: NEPH's earnings are forecast to decline over the next 3 years (-55.3% per year).

High Growth Earnings: NEPH's earnings are forecast to decline over the next 3 years.

Revenue vs Market: NEPH's revenue (8.8% per year) is forecast to grow slower than the US market (10.5% per year).

High Growth Revenue: NEPH's revenue (8.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NEPH's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 08:43
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nephros, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Marc WiesenbergerB. Riley Securities, Inc.
Anthony VendettiMaxim Group